The Human Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit is a ready to use kit manufactured by using high quality antibodies sets, plates, solutions and detection molecules. This EIA test for Human Thrombin activatable fibrinolysis inhibitor( TAFI ) will yield accurate and reproducible results. The specially designed buffers ensure the most suitable conditions for the detection reactions.
Store all components and reagents of the Thrombin activatable fibrinolysis inhibitor( TAFI )ELISA kit refrigerated and +4 degrees Celcius. For a long term storage the kit's components may be frozen at -20 but cycles of freezing and thawing should be strictly avoided as they denaturate the polypeptide chains in the antibodies and controlls, thus causing a reduction in the kit's detection ability and specificity which changes will lead to inconsistant results.
Small volumes from the liquid components of the Thrombin activatable fibrinolysis inhibitor( TAFI )EIA kit may get caught on the walls and lid of the vials. Prior to use, briefly centrifuge the vial to ensure that all of the content is gathered on the bottom.
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.